Carrie Cox - Cardinal Health Independent Director
| CAH Stock | USD 122.24 0.39 0.32% |
Director
Ms. Carrie S. Cox serves as Independent Director of Cardinal Health Inc. Ms. Cox has served as Chief Executive Officer of Humacyte, Inc., a privately held, development stage company focused on regenerative medicine, since 2010 and as Chairman of Humacyte since 2013. From 2003 to 2009, she served as Executive Vice President and President of Global Pharmaceuticals at ScheringPlough Corporationrationration, a multinational branded pharmaceutical manufacturer since 2009.
| Age | 62 |
| Tenure | 15 years |
| Address | 7000 Cardinal Place, Dublin, OH, United States, 43017 |
| Phone | 614 757 5000 |
| Web | https://www.cardinalhealth.com |
Cardinal Health Management Efficiency
The company has Return on Asset of 0.0318 % which means that on every $100 spent on assets, it made $0.0318 of profit. This is way below average. Cardinal Health's management efficiency ratios could be used to measure how well Cardinal Health manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Cardinal Health's Return On Tangible Assets are decreasing as compared to previous years. The Cardinal Health's current Return On Assets is estimated to increase to 0.05, while Return On Capital Employed is projected to decrease to 0.13. As of now, Cardinal Health's Total Current Assets are increasing as compared to previous years. The Cardinal Health's current Intangible Assets is estimated to increase to about 2.2 B, while Non Current Assets Total are projected to decrease to under 6.5 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Garrey Carruthers | Molina Healthcare | 80 | |
| Gail Wilensky | UnitedHealth Group Incorporated | 76 | |
| John Noseworthy | UnitedHealth Group Incorporated | 69 | |
| Daniel Cooperman | Molina Healthcare | 70 | |
| Tommy Thompson | Centene Corp | 78 | |
| Richard Schapiro | Molina Healthcare | 65 | |
| Michele Hooper | UnitedHealth Group Incorporated | 68 | |
| Eric Wiseman | Cigna Corp | 65 | |
| Timothy Flynn | UnitedHealth Group Incorporated | 64 | |
| William Ballard | UnitedHealth Group Incorporated | 77 | |
| David Jones | Humana Inc | 71 | |
| William Trubeck | Centene Corp | 74 | |
| William McDonald | Humana Inc | 64 | |
| Donna Zarcone | Cigna Corp | 63 | |
| David Steward | Centene Corp | 68 | |
| Robert Ditmore | Centene Corp | 86 | |
| Frank Bisignano | Humana Inc | 62 | |
| Mark McClellan | Cigna Corp | 57 | |
| Glenn Renwick | UnitedHealth Group Incorporated | 64 | |
| George Kurian | Cigna Corp | 54 | |
| Kimberly Ross | Cigna Corp | 56 | |
Management Performance
| Return On Asset | 0.0318 |
Cardinal Health Leadership Team
Elected by the shareholders, the Cardinal Health's board of directors comprises two types of representatives: Cardinal Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardinal. The board's role is to monitor Cardinal Health's management team and ensure that shareholders' interests are well served. Cardinal Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardinal Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Patricia English, Senior President | ||
| Jorge Sahlieh, President Distribution | ||
| John Losh, Independent Director | ||
| John Adams, Senior Counsel | ||
| Kevin Moran, VP Relations | ||
| Rob Schlissberg, President Solutions | ||
| Michael Kaufmann, Chief Executive Officer, Director | ||
| John Weiland, Independent Director | ||
| Sheri Edison, Independent Director | ||
| Nancy Killefer, Independent Director | ||
| Patricia Hall, Independent Director | ||
| Stephen Mason, Chief Executive Officer - Medical Segment | ||
| Calvin Darden, Independent Director | ||
| Akhil Johri, Independent Director | ||
| David Wilson, President Cordis | ||
| Michele Holcomb, Executive Vice President - Strategy and Corporate Development | ||
| Colleen Arnold, Independent Director | ||
| Carrie Cox, Independent Director | ||
| Michael Pintek, President Solutions | ||
| Dean Scarborough, Independent Director | ||
| Craig Cowman, Executive Services | ||
| Deborah Weitzman, Chief Distribution | ||
| Jason Hollar, Chief Financial Officer | ||
| Patrick Pope, Executive Secretary | ||
| Matt Sims, Vice Relations | ||
| Gregory Kenny, Independent Non-Executive Chairman of the Board | ||
| Victor Crawford, Chief Executive Officer - Pharmaceutical segment | ||
| Jessica Mayer, Chief Legal and Compliance Officer | ||
| Bruce Downey, Independent Director | ||
| Brad Cochran, Executive Distribution | ||
| Aaron JD, Chief Officer | ||
| Mary Scherer, Senior Officer | ||
| Brian Rice, Executive Vice President, Chief Information Officer and Customer Support Services | ||
| David Evans, Interim Chief Financial Officer | ||
| Ola Snow, Chief Human Resource Officer | ||
| Ben Brinker, President Chain | ||
| Patricia CPA, Senior President | ||
| Aaron Alt, Chief Officer | ||
| Emily Gallo, SVP Logistics | ||
| Michelle Greene, Exec Services |
Cardinal Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cardinal Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.0318 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 31.97 B | ||||
| Shares Outstanding | 242.01 M | ||||
| Shares Owned By Insiders | 0.25 % | ||||
| Shares Owned By Institutions | 89.55 % | ||||
| Number Of Shares Shorted | 5.98 M | ||||
| Price To Earning | 16.00 X | ||||
| Price To Book | 16.07 X |
Currently Active Assets on Macroaxis
When determining whether Cardinal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cardinal Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cardinal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cardinal Health Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardinal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in Cardinal Stock please use our How to Invest in Cardinal Health guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardinal Health. If investors know Cardinal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardinal Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 48.135 | Dividend Share 2.012 | Earnings Share 5.2 | Revenue Per Share 921.782 | Quarterly Revenue Growth (0.04) |
The market value of Cardinal Health is measured differently than its book value, which is the value of Cardinal that is recorded on the company's balance sheet. Investors also form their own opinion of Cardinal Health's value that differs from its market value or its book value, called intrinsic value, which is Cardinal Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardinal Health's market value can be influenced by many factors that don't directly affect Cardinal Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardinal Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardinal Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardinal Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.